Abstract:Objective: Response to antidepressant treatment in major depressive disorder varies substantially between individuals, which lengthens the process of finding effective treatment. The authors sought to determine whether a multimodal machine learning approach could predict early sertraline response in patients with major depressive disorder. They assessed the predictive contribution of MR neuroimaging and clinical assessments at baseline and after 1 week of treatment. Methods: This was a preregistered secondary analysis of data from the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) study, a multisite double-blind, placebo-controlled randomized clinical trial that included 296 adult outpatients with unmedicated recurrent or chronic major depressive disorder. MR neuroimaging and clinical data were collected before and after 1 week of treatment. Performance in predicting response and remission, collected after 8 weeks, was quantified using balanced accuracy (bAcc) and area under the receiver operating characteristic curve (AUROC) scores. Results: A total of 229 patients were included in the analyses (mean age, 38 years [SD=13]; 66% female). Internal cross-validation performance in predicting response to sertraline (bAcc=68% [SD=10], AUROC=0.73 [SD=0.03]) was significantly better than chance. External cross-validation on data from placebo nonresponders (bAcc=62%, AUROC=0.66) and placebo nonresponders who were switched to sertraline (bAcc=65%, AUROC=0.68) resulted in differences that suggest specificity for sertraline treatment compared with placebo treatment. Finally, multimodal models outperformed unimodal models. Conclusions: The study results confirm that early sertraline treatment response can be predicted; that the models are sertraline specific compared with placebo; that prediction benefits from integrating multimodal MRI data with clinical data; and that perfusion imaging contributes most to these predictions. Using this approach, a lean and effective protocol could individualize sertraline treatment planning to improve psychiatric care.

Prediction of response of chronic depression to imipramine.

Imipramine Treatment for Chronic Depression

Imipramine and social-vocational adjustment in chronic depression.

Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge

Predictors of Treatment Response in Anxious-Depressed Adolescents With School Refusal

Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial

Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients

Combining machine learning algorithms for prediction of antidepressant treatment response

Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder

P.3.17 Do Patients Benefit from Practice? an Fmri Study in First Episode Schizophrenia

SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli

Early symptom improvement and other clinical predictors of response to repetitive transcranial magnetic stimulation for depression

An Electroencephalographic Signature Predicts Antidepressant Response in Major Depression

Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo

Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials

Predictors of response to accelerated rTMS in the treatment of treatment-resistant depression

Chronic exposure to imipramine induces a switch from depression-like to mania-like behavior in female serotonin transporter knockout rats: Role of BDNF signaling in the infralimbic cortex

Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder

Predictive modeling of antidepressant efficacy based on cognitive neuropsychological theory

Electroencephalography for predicting antidepressant treatment success: A systematic review and meta-analysis

Repetitive transcranial magnetic stimulation: Course and early prediction of response in depression